Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia
Infections remain a leading cause of morbidity and mortality in patients with reduced immunity caused by haematological disease and chemotherapy‐induced neutropenia. We evaluated the clinical and microbiological impact of discontinuing fluoroquinolone prophylaxis in these patients.
No Supplementary Data
No Article Media